EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524

Jodie Green iD, Harriet Syme iD, Sarah Tayler iD

Journal of Veterinary Internal Medicine · 2023

DOI: 10.1111/jvim.16804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2023. Verfasst von Jodie Green und 2 weiteren Autor:innen. Beteiligte Einrichtung: Royal Veterinary College, Hatfield, UK. Hauptthemen laut MEDLINE: Feline Infectious Peritonitis, Coronavirus, Feline, Cat Diseases. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

GS-441524 has been successfully used to treat feline infectious peritonitis (FIP) in cats. However, the use of its prodrug, remdesivir, in combination with a PO GS-441524 containing product for the treatment of FIP has not yet been described.

Objectives

Describe treatment protocols, response to treatment and outcomes in cats with FIP treated with a combination of PO GS-441524 and injectable remdesivir. Animals Thirty-two client-owned cats diagnosed with effusive or non-effusive FIP including those with ocular and neurological involvement.

Methods

Cats diagnosed with FIP at a single university hospital between August 2021 and July 2022 were included. Variables were recorded from time of diagnosis, and subsequent follow-up information was obtained from the records of referring veterinarians. All surviving cats were observed for the entire 12-week treatment period.

Results

Cats received treatment with different combinations of IV remdesivir, SC remdesivir, and PO GS-441524 at a median (range) dosage of 15 (10-20) mg/kg. Clinical response to treatment was observed in 28 of 32 cats (87.5%) in a median (range) of 2 (1-5) days. Twenty-six of 32 cats (81.3%) were alive and in clinical and biochemical remission at the end of the 12-week treatment period. Six of 32 cats (18.8%) died or were euthanized during treatment with 4 of the 6 cats (66%) dying within 3 days of starting treatment.

Conclusions

We describe the effective use of injectable remdesivir and PO GS-441524 for the treatment of FIP in cats. Success occurred using different treatment protocols and with different presentations of FIP including cats with ocular and neurological involvement.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feline Infectious PeritonitisCoronavirus, FelineCat DiseasesHumansCatsAnimalsAdenosine MonophosphateAlanineAdenosine

Stichwörter der Autor:innen

FIPcoronavirusfelinemicrobiologyneurologyviral

Substanzen

remdesivirAdenosine MonophosphateAlanineGS-441524Adenosine

Autor:innen und Institutionen

  • Royal Veterinary College, Hatfield, UK.

ORCID-Profile: Jodie Green, Harriet Syme, Sarah Tayler

Zitieren

APA

Green, J., Syme, H., & Tayler, S. (2023). Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16804

Vancouver

Green J, Syme H, Tayler S. Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524. Journal of Veterinary Internal Medicine. 2023. doi:10.1111/jvim.16804

BibTeX
@article{Green2023,
  author = {Green, Jodie and Syme, Harriet and Tayler, Sarah},
  title = {Thirty-two cats with effusive or non-effusive feline infectious peritonitis treated with a combination of remdesivir and GS-441524},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2023},
  doi = {10.1111/jvim.16804}
}
Kostenlos starten →